Prediction: The Tiny AI Stock Has a Massive Opportunity in Optical Computing

Vandita Jadeja

Wed, August 19, 2026 at 3:30 PM GMT+3 4 min read

Quick Read

POET Technologies (NASDAQ: POET) trades at $9.40, which is half its 52-week high, but a $50M Lumilens purchase order with $500M+ framework potential supports our $21.14 BUY target.
Peers Credo (CRDO) at a $52.7B market cap and Applied Optoelectronics (AAOI) at $13.1B show exactly what POET could become once design wins convert to revenue.
A $400M offering loaded POET with ~$796M in cash, but a price-to-sales ratio of 965 and three straight revenue misses leave no room for execution errors.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Poet Technologies didn't make the cut. Grab the names FREE today.

Optical computing has become one of the most closely watched sub-themes in the AI infrastructure buildout, and few pure-plays sit closer to the bleeding edge than POET Technologies (NASDAQ:POET).

Shutterstock

At $9.40, the stock trades well below its 52-week high of $20.81 yet remains valued as if commercial scale is treated as inevitable. Our 24/7 Wall St. price target for POET is $21.14, implying 124.89% upside. Our recommendation is buy with medium confidence.

24/7 Wall St. Price Target Summary

A Volatile Year and a Cash-Fortified Balance Sheet

POET has been volatile. Shares are up 86.51% over the past year and 48.5% year to date, but the path included a spike to nearly $15.97 in May 2026 and a slide back toward single digits.

Q2 FY26 revenue came in at $569,925, up 112.29% year over year but missing expectations by 17.58%. GAAP EPS of -$0.07 was in line with estimates. POET closed the quarter with roughly $796 million in combined cash and short-term investments after a $400 million registered offering at $21 per unit. Execution risk remains, but funding risk is off the table.

Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Poet Technologies didn't make the cut. Grab the names FREE today.

Why Bulls See a Breakout Ahead

The bull thesis rests on commercial validation of the Optical Interposer platform. The Lumilens deal anchors the case: an initial $50 million purchase order for EOI-based optical engines, with framework potential of $500 million-plus over five years. Joint development with LITEON ties to a 1.6T optical module, and management targets ship 30,000-plus optical engines in 2026.

AI cluster Ethernet optics is projected at $26 billion in 2026, roughly 60% YoY growth (we profiled seven of the non-chip suppliers riding this same buildout in a free AI infrastructure report). Our bull-case scenario points to $22.02 on a one-year view.

What Could Go Wrong

POET carries an accumulated deficit of roughly $321 million, 78.7 million warrants outstanding, and a price-to-sales ratio of 965. That valuation leaves no room for slippage, and the last three quarters all missed revenue consensus.

Bulls counter that miss magnitudes are shrinking as production ramps and the balance sheet now supports Malaysia capacity expansion without dilution pressure. Our bear-case target sits at $14.08, which still implies positive returns from current levels.

How POET Compares to Credo and Applied Optoelectronics

Credo Technology (NASDAQ:CRDO) is the closest "what POET wants to become" comparison. Credo posted Q4 FY26 revenue of $437 million, up 157% YoY, and carries a market cap near $52.7 billion. That is roughly 32x POET's $1.65 billion valuation on materially proven revenue, which frames POET's target as ambitious yet achievable if design wins convert.

Applied Optoelectronics (NASDAQ:AAOI) is the operational analog. AAOI delivered Q2 FY26 revenue of $191.9 million, up 86% YoY, with 800G volumes doubling sequentially. At a $13.1 billion market cap, AAOI shows what happens when a photonics name clears the qualification hurdle. The peer set supports our 24/7 Wall St. price target as a defensible base case.

POET Price Prediction 2026-2030

Our 24/7 Wall St. price target of $21.14 backs a buy rating at medium confidence. The scale tips on the Lumilens ramp and Malaysia capacity coming online.

The bullish scenario builds on POET showing sequential revenue acceleration into Q4 with visible progress on 800G production. The bearish scenario materializes if another quarter misses consensus by double digits and warrant dilution accelerates.

These projections assume POET converts its Lumilens framework and Malaysia capacity into revenue at scale. Significant upside or downside could result from execution on 800G production timing and continued AI capex velocity.